EDAP TMS SA Deferred Income Tax Expense (Benefit)
EDAP TMS SA (FOCL) reported Deferred Income Tax Expense (Benefit) of -$165.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-25
EUR
| Period end | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | -112.00K EUR 20-F · filed 2025-03-27 | ||
| 2023-12-31 | 34.00K EUR 20-F · filed 2025-03-27 | ||
| 2022-12-31 | 101.00K EUR 20-F · filed 2025-03-27 | ||
| 2021-12-31 | -563.00K EUR 20-F · filed 2024-03-28 | ||
| 2020-12-31 | 45.00K EUR 20-F · filed 2023-04-07 | ||
| 2019-12-31 | -108.00K EUR 20-F · filed 2022-04-08 | ||
| 2018-12-31 | -157.00K EUR 20-F · filed 2021-04-07 | ||
| 2017-12-31 | -146.00K EUR 20-F · filed 2020-04-16 | ||
| 2017-06-30 | -40.00K EUR 6-K · filed 2017-09-21 | ||
| 2016-12-31 | 32.00K EUR 20-F · filed 2019-04-12 | 65.00K EUR 20-F · filed 2017-04-03 | |
| 2016-06-30 | 49.00K EUR 6-K · filed 2017-09-21 | ||
| 2015-12-31 | -7.00K EUR 20-F · filed 2018-04-30 | 23.00K EUR 20-F · filed 2016-04-04 | |
| 2015-06-30 | 22.00K EUR 6-K · filed 2016-09-27 | ||
| 2014-12-31 | -18.00K EUR 20-F · filed 2017-04-03 | ||
| 2014-06-30 | -9.00K EUR 6-K · filed 2015-09-25 | ||
| 2013-12-31 | -65.00K EUR 20-F · filed 2014-04-03 | ||
| 2012-12-31 | -52.00K EUR 20-F · filed 2014-04-03 | ||
| 2012-06-30 | -6.00K EUR 6-K/A · filed 2012-10-04 | ||
| 2011-12-31 | 293.00K EUR 20-F · filed 2014-04-03 | ||
| 2011-06-30 | -1.00K EUR 6-K/A · filed 2012-10-04 | ||
| 2010-12-31 | 180.00K EUR 20-F/A · filed 2013-04-25 | ||
| 2009-12-31 | -57.00K EUR 20-F/A · filed 2012-05-21 |
USD
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$165.00K 10-K · filed 2026-03-25 |
| 2024-12-31 | -$121.00K 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B |